Fundamental Analysis of ADITXT INC(NASDAQ:ADTX) stock

Fundamental Rating

ADTX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 571 industry peers in the Biotechnology industry. ADTX may be in some trouble as it scores bad on both profitability and health. ADTX is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ADTX has reported negative net income.

ADTX had a negative operating cash flow in the past year.

In the past 5 years ADTX always reported negative net income.

ADTX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ADTX has a worse Return On Assets (-152.65%) than 85.54% of its industry peers.

ADTX has a Return On Equity of -659.65%. This is amonst the worse of the industry: ADTX underperforms 81.83% of its industry peers.

		Industry Rank	Sector Rank
ROA	-152.65%
ROE	-659.65%
ROIC	N/A

ROA(3y)-203.04%

ROA(5y)-1107.46%

ROE(3y)-396.62%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ADTX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ADTX does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ADTX has been reduced compared to 1 year ago.

The number of shares outstanding for ADTX has been increased compared to 5 years ago.

ADTX has a worse debt/assets ratio than last year.

2.2 Solvency

ADTX has an Altman-Z score of -11.94. This is a bad value and indicates that ADTX is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -11.94, ADTX is not doing good in the industry: 78.13% of the companies in the same industry are doing better.

ADTX has a Debt/Equity ratio of 0.98. This is a neutral value indicating ADTX is somewhat dependend on debt financing.

ADTX has a Debt to Equity ratio of 0.98. This is in the lower half of the industry: ADTX underperforms 77.95% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.98
Debt/FCF	N/A
Altman-Z	-11.94

ROIC/WACCN/A

WACC22.32%

2.3 Liquidity

A Current Ratio of 0.07 indicates that ADTX may have some problems paying its short term obligations.

The Current ratio of ADTX (0.07) is worse than 98.59% of its industry peers.

ADTX has a Quick Ratio of 0.07. This is a bad value and indicates that ADTX is not financially healthy enough and could expect problems in meeting its short term obligations.

ADTX has a worse Quick ratio (0.05) than 99.12% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.07
Quick Ratio	0.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ADTX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 81.22%, which is quite impressive.

The Revenue for ADTX has decreased by -65.29% in the past year. This is quite bad

EPS 1Y (TTM)81.22%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-342.55%

Revenue 1Y (TTM)-65.29%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-79.96%

3.2 Future

The Earnings Per Share is expected to grow by 40.13% on average over the next years. This is a very strong growth

ADTX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 395.36% yearly.

EPS Next Y99.83%

EPS Next 2Y40.13%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year45.65%

Revenue Next 2Y395.36%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ADTX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ADTX. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ADTX's earnings are expected to grow with 40.13% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y40.13%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ADTX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ADITXT INC

NASDAQ:ADTX (11/26/2024, 7:58:36 PM)

After market: 0.325 0 (-1.49%)

0.3299

-0.07 (-17.53%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap4.69M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-152.65%
ROE	-659.65%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.01

Health

		Industry Rank	Sector Rank
Debt/Equity	0.98
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.07
Quick Ratio	0.05
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)81.22%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y99.83%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-65.29%

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

ADITXT INC (ADTX)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens